281 related articles for article (PubMed ID: 27078700)
21. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
Rajmohan R; Reddy PH
J Alzheimers Dis; 2017; 57(4):975-999. PubMed ID: 27567878
[TBL] [Abstract][Full Text] [Related]
22. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
23. Effect of amyloid-Β (25-35) in hyperglycemic and hyperinsulinemic rats, effects on phosphorylation and O-GlcNAcylation of tau protein.
Lozano L; Guevara J; Lefebvre T; Ramos-Martinez I; Limón D; Díaz A; Cerón E; Zenteno E
Neuropeptides; 2017 Jun; 63():18-27. PubMed ID: 28427866
[TBL] [Abstract][Full Text] [Related]
24. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Park J; Lai MKP; Arumugam TV; Jo DG
Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
[TBL] [Abstract][Full Text] [Related]
25. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
26. O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment.
Kim C; Nam DW; Park SY; Song H; Hong HS; Boo JH; Jung ES; Kim Y; Baek JY; Kim KS; Cho JW; Mook-Jung I
Neurobiol Aging; 2013 Jan; 34(1):275-85. PubMed ID: 22503002
[TBL] [Abstract][Full Text] [Related]
27. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB
Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
29. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
30. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
[TBL] [Abstract][Full Text] [Related]
31. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
32. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
33. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
[TBL] [Abstract][Full Text] [Related]
34. Role of APP and Aβ in synaptic physiology.
Wang Z; Yang L; Zheng H
Curr Alzheimer Res; 2012 Feb; 9(2):217-26. PubMed ID: 21605029
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels.
Simón AM; Schiapparelli L; Salazar-Colocho P; Cuadrado-Tejedor M; Escribano L; López de Maturana R; Del Río J; Pérez-Mediavilla A; Frechilla D
Neurobiol Dis; 2009 Mar; 33(3):369-78. PubMed ID: 19101630
[TBL] [Abstract][Full Text] [Related]
36. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
37. Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice.
Huesa G; Baltrons MA; Gómez-Ramos P; Morán A; García A; Hidalgo J; Francés S; Santpere G; Ferrer I; Galea E
J Alzheimers Dis; 2010; 19(1):37-56. PubMed ID: 20061625
[TBL] [Abstract][Full Text] [Related]
38. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats.
Lin L; Yang SS; Chu J; Wang L; Ning LN; Zhang T; Jiang Q; Tian Q; Wang JZ
J Alzheimers Dis; 2014; 41(4):1149-63. PubMed ID: 24787918
[TBL] [Abstract][Full Text] [Related]
39. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
40. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
